Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, Michigan, USA.
Neuroscience Graduate Program, University of Michigan, Ann Arbor, Michigan, USA.
Cannabis Cannabinoid Res. 2024 Oct;9(5):1217-1234. doi: 10.1089/can.2023.0246. Epub 2024 Apr 29.
Dysregulation of the endocannabinoid (eCB) system is implicated in various stress-related neuropsychiatric disorders (SRDs), including anxiety, depression, and post-traumatic stress disorder (PTSD). In this systematic review and meta-analysis, our objectives were to characterize circulating anandamide (AEA) and 2-arachidonoylglycerol (2-AG) concentrations at rest and in response to acute laboratory-based psychosocial stress in individuals with SRDs and without (controls). Our primary aims were to assess the effects of acute psychosocial stress on eCB concentrations in controls (Aim 1), compare baseline (prestress) eCB concentrations between individuals with SRDs and controls (Aim 2), and explore differential eCB responses to acute psychosocial stress in individuals with SRDs compared with controls (Aim 3). On June 8, 2023, a comprehensive review of the MEDLINE (PubMed) database was conducted to identify original articles meeting inclusion criteria. A total of 1072, 1341, and 400 articles were screened for inclusion in Aims 1, 2, and 3, respectively. Aim 1, comprised of seven studies in controls, revealed that most studies reported stress-related increases in AEA (86%, with 43% reporting statistical significance) and 2-AG (83%, though none were statistically significant except for one study in saliva). However, meta-analyses did not support these patterns (s>0.05). Aim 2, with 20 studies, revealed that most studies reported higher baseline concentrations of both AEA (63%, with 16% reporting statistical significance) and 2-AG (60%, with 10% reporting statistical significance) in individuals with SRDs compared with controls. Meta-analyses confirmed these findings (s<0.05). Aim 3, which included three studies, had only one study that reported statistically different stress-related changes in 2-AG (but not AEA) between individuals with PTSD (decrease) and controls (increase), which was supported by the meta-analysis (<0.001). Meta-analyses showed heterogeneity across studies and aims (=14-97%). Despite substantial heterogeneity in study characteristics, samples, and methodologies, consistent patterns emerged, including elevated baseline AEA and 2-AG in individuals with SRDs compared with controls, as well as smaller stress-related increases in 2-AG in individuals with SRDs compared with controls. To consider eCBs as reliable biomarkers and potential intervention targets for SRDs, standardized research approaches are needed to clarify the complex relationships between eCBs, SRDs, and psychosocial stress.
内源性大麻素(eCB)系统的失调与各种与应激相关的神经精神疾病(SRDs)有关,包括焦虑、抑郁和创伤后应激障碍(PTSD)。在这项系统评价和荟萃分析中,我们的目标是描述在患有 SRD 和无(对照组)的个体中,静息时和急性实验室心理社会应激下循环花生四烯酸乙醇胺(AEA)和 2-花生四烯酸甘油(2-AG)的浓度。我们的主要目的是评估急性心理社会应激对对照组中 eCB 浓度的影响(目的 1),比较患有 SRD 和对照组的个体之间的基线(应激前)eCB 浓度(目的 2),并探索患有 SRD 的个体与对照组相比,对急性心理社会应激的不同 eCB 反应(目的 3)。2023 年 6 月 8 日,对 MEDLINE(PubMed)数据库进行了全面审查,以确定符合纳入标准的原始文章。共有 1072、1341 和 400 篇文章分别用于纳入目的 1、2 和 3。目的 1 包含对照组的七项研究,结果表明,大多数研究报告应激相关的 AEA 增加(86%,其中 43%有统计学意义)和 2-AG(83%,尽管除了一项唾液研究外,没有一项有统计学意义)。然而,荟萃分析并不支持这些模式(s>0.05)。目的 2 包含 20 项研究,结果表明,大多数研究报告患有 SRD 的个体的基线 AEA(63%,其中 16%有统计学意义)和 2-AG(60%,其中 10%有统计学意义)浓度较高,与对照组相比。荟萃分析证实了这些发现(s<0.05)。目的 3 包括三项研究,其中只有一项研究报告 PTSD(减少)与对照组(增加)之间 2-AG(而不是 AEA)的应激相关变化有统计学意义,荟萃分析支持这一发现(<0.001)。荟萃分析显示,研究之间存在异质性(=14-97%)。尽管研究特征、样本和方法存在很大异质性,但出现了一致的模式,包括与对照组相比,SRD 个体的基线 AEA 和 2-AG 升高,以及与对照组相比,SRD 个体的 2-AG 应激相关增加较小。为了将 eCB 视为 SRD 的可靠生物标志物和潜在干预靶点,需要采用标准化的研究方法来阐明 eCB、SRD 和心理社会应激之间的复杂关系。
Cochrane Database Syst Rev. 2011-12-7
Cochrane Database Syst Rev. 2016-4-4
Cochrane Database Syst Rev. 2015-1-20
Cochrane Database Syst Rev. 2016-3-12
Cochrane Database Syst Rev. 2024-8-2
Psychopharmacol Bull. 2024-7-8
Cochrane Database Syst Rev. 2015-3-5
Psychopharmacology (Berl). 2025-7-25
Psychopharmacology (Berl). 2025-7-11
Int J Mol Sci. 2025-6-9
Npj Ment Health Res. 2025-4-24
Psychopharmacology (Berl). 2024-11-16
Neurobiol Stress. 2023-1-11
J Anxiety Disord. 2023-1
Compr Psychoneuroendocrinol. 2021-6-21
Global Spine J. 2022-9
Chronic Stress (Thousand Oaks). 2022-6-9